Klas Holmlund, CFA

Klas Holmlund, CFA has extensive work experience in various financial roles. Klas is currently the Chief Financial Officer at Lyndra Therapeutics since December 2021. Prior to that, they served as the Head of Treasury at Vertex Pharmaceuticals for over 11 years, from November 2010 to December 2021. In addition, they were a Board Member at New England AFP from July 2013 to June 2015. Before joining Vertex Pharmaceuticals, Klas held various treasury roles at General Motors from June 2007 to July 2010. Klas started their career as an Investment Analyst at Evergreen Investments in December 2001 and worked there until July 2005.

Klas Holmlund, CFA, holds an MBA from the Yale School of Management. Klas also has a Master of Science degree in Finance from Boston College and a Bachelor's degree in Economics from Lewis & Clark College. In addition, they have obtained the Chartered Financial Analyst (CFA) certification from the CFA Institute.